Heat Biologics, Inc. (HTBX) Social Stream



Heat Biologics, Inc. (HTBX): $2.38

0.01 (+0.42%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add HTBX to Watchlist
Sign Up

Industry: Biotech


Ranked

of 395

in industry

Featured Post From StockTwits About HTBX

$HTBX Heat Biologics Corporate Milestones for 2021:
✅William Ostrander appointed CFO - January 2021 ✅Various coronavirus vaccine milestones – 2021
o Began manufacturing process for ZVX-60 - January 2021 o Investigational New Drug (IND) Application
o Phase I launch
✅Positive interim survival data from HS-110 Ph2 NSCLC - February 2021 ✅Discussion with potential partners – ongoing
✅Complete HS-130 Phase I trial – 1H:21
✅Complete PTX-35 Phase I trial – 1H:21
✅Data readout at ASCO for HS-110 – June 2021 ✅ End of Phase II meeting for HS-110 – 2021
✅Data readout on Phase I HS-130 – 2H:21
✅Data readout on Phase I PTX-35 – 2H:21
✅Additional detail regarding Phase III target NSCLC settings for HS-110
Tradelike1, published August 16, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4454 seconds.